Two new drugs for Parkinson's just hit the market
November 1997
Two new drugs for Parkinson's just hit the market...ropinirole (Requip, SmithKline Beecham) and tolcapone (Tasmar, Roche).
Requip is a second-generation dopamine agonist.
It's more selective for dopamine than the first generation agonists...Permax (pergolide) and Parlodel (bromocriptine).
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive